Once Daily Long-Acting Muscarinic Antagonists Administered in the Evening for Prevention of Chronic Obstructive Pulmonary Disease Exacerbations Requiring Hospitalization or Death from Any Cause

Clinical trial NCT05563675 · COMPLETED

Trial details

NCT number: NCT05563675
Sponsor: Chronic Obstructive Pulmonary Disease Trial Network, Denmark
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

COPD Exacerbation

Start date: 2023-01-27
Primary completion: 2024-06-01
Enrollment: 10011

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.